论文部分内容阅读
慢性心力衰竭是多数心血管疾病的最终归宿,在心脏泵血、充盈能力的下降的同时,往往伴有心肌重构。在过去的2个世纪,随着药物治疗的不断发展,再同步化治疗、植入式心律转复除颤器等新技术的不断普及,心力衰竭患者的预后得到了改善,但慢性心力衰竭的发病率和病死率仍然居高不下。近年来,随着介入治疗和器械的不断发展,各种经导管心脏结构性治疗的方法不断涌现,给慢性心力衰竭患者的治疗带来了新希望。本文针对上述经导管结构性治疗慢性心力衰竭的技术作一介绍。
Chronic heart failure is the ultimate fate of most cardiovascular diseases, cardiac pumping, filling capacity decline, often accompanied by myocardial remodeling. Over the past two centuries, with the continuous development of medical treatment, resynchronization therapy and the continuous popularization of new technologies such as implantable cardioverter defibrillators, the prognosis of heart failure patients has been improved, but the chronic heart failure Incidence and mortality rates remain high. In recent years, with the continuous development of interventional therapy and instruments, a variety of methods for the structural therapy of the transcatheter heart continue to emerge, bringing new hope to the treatment of patients with chronic heart failure. This article addresses the above techniques for the treatment of chronic heart failure by catheterization.